You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TSS50

Showing 1 - 25 of 196
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelofibrosis, Moderate Thrombocytopenia Trial (Selinexor)

Not yet recruiting
  • Myelofibrosis
  • Moderate Thrombocytopenia
  • (no location specified)
Jul 31, 2023

Myelofibrosis Trial in Worldwide (Selinexor, Physician's Choice Treatment)

Recruiting
  • Myelofibrosis
  • Los Angeles, California
  • +41 more
Jan 30, 2023

Myelofibrosis Trial in United States (Selinexor, Ruxolitinib)

Recruiting
  • Myelofibrosis
  • Duarte, California
  • +4 more
Jan 30, 2023

Myelofibrosis Trial in China (TQ05105 Tablets, TQB3617 Capsules)

Not yet recruiting
  • Myelofibrosis
  • TQ05105 Tablets
  • TQB3617 Capsules
  • Guangzhou, Guangdong, China
  • +19 more
Nov 7, 2023

Bone Marrow Fibrosis, Myeloproliferative Tumor Trial in Cleveland (Captopril)

Not yet recruiting
  • Bone Marrow Fibrosis
  • Myeloproliferative Neoplasm
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
Jan 30, 2023

Respiratory Syncytial Virus (RSV) Trial in London (RV299, Placebo)

Completed
  • Respiratory Syncytial Virus (RSV)
  • London, United Kingdom
    Pfizer
Oct 5, 2023

Influenza Infection Trial (Molnupiravir, Placebo molnupiravir, Placebo oseltamivir)

Not yet recruiting
  • Influenza Infection
  • (no location specified)
Apr 5, 2023

Myeloproliferative Tumor, MPN, Essential Thrombocythemia Trial in Orange (N-Acetylcysteine)

Active, not recruiting
  • Myeloproliferative Neoplasm
  • +4 more
  • Orange, California
    Chao Family Comprehensive Cancer Center, University of Californi
Jan 6, 2023

Myeloproliferative Tumor, Chronic Neutrophilic Leukemia, MDS Trial in Tampa (Fedratinib Pill)

Recruiting
  • Myeloproliferative Neoplasm
  • +2 more
  • Fedratinib Pill
  • Tampa, Florida
    Moffitt Cancer Center
Jun 15, 2022

Heart Failure Trial (Finerenone, Placebo)

Not yet recruiting
  • Heart Failure
  • (no location specified)
Sep 11, 2023

Respiratory Monitoring System Safety and Performance Study

Recruiting
  • Pulmonary Function Test
  • +4 more
    • Philadelphia, Pennsylvania
      Thomas Jefferson University Hospital
    Apr 2, 2023

    Myelofibrosis, Primary Myelofibrosis, Post-PV MF Trial in Canton (TL-895, Ruxolitinib)

    Recruiting
    • Myelofibrosis
    • +3 more
    • Birmingham, Alabama
    • +13 more
    Jan 10, 2023

    Acute Heart Failure Trial in Japan (Empagliflozin 10 MG, Placebo)

    Recruiting
    • Acute Heart Failure
    • Empagliflozin 10 MG
    • Placebo
    • Anjo, Aichi, Japan
    • +50 more
    Jan 21, 2023

    Myelofibrosis Trial in Jinan (Ruxolitinib)

    Recruiting
    • Myelofibrosis
    • Jinan, Shandong, China
      Qilu Hospital of Shandong University
    Jul 3, 2022

    Ruxolitinib in Patients With Myelofibrosis

    Completed
    • Myelofibrosis
    • (no location specified)
    Jun 5, 2022

    Primary Myelofibrosis, Anemia Trial in Worldwide (Luspatercept)

    Completed
    • Primary Myelofibrosis
    • Anemia
    • Phoenix, Arizona
    • +24 more
    Aug 17, 2022

    Myelofibrosis Trial in Hangzhou (Jaktinib Hydrochloride Tablets)

    Recruiting
    • Myelofibrosis
    • Jaktinib Hydrochloride Tablets
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital of Medical School of Zhejiang Univ
    Nov 28, 2022

    Erectile Dysfunction, Acupuncture Therapy, Median Nerve Disease Trial in Changsha (electroacupuncture)

    Recruiting
    • Erectile Dysfunction
    • +2 more
    • electroacupuncture
    • Changsha, Hunan, China
      The First Affiliated Hospital of Hunan University of Chinese Med
    Feb 27, 2023

    Vaginosis, Bacterial Trial in Aversa (Logusgyn ovules, Logusgyn Lavander, Placebo)

    Completed
    • Vaginosis, Bacterial
    • Logusgyn ovules
    • +2 more
    • Aversa, Campania, Italy
      Ospedale San Giovanni Moscati
    Dec 5, 2022

    Pituitary Tumor Trial run by the NINDS (ESC)

    Completed
    • Pituitary Neoplasm
    • ESC
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 25, 2022

    Covid19, SARS-CoV Infection, Corona Virus Infection Trial in London (SARS-CoV-2 Virus, Remdesivir)

    Completed
    • Covid19
    • +4 more
    • London, United Kingdom
    • +1 more
    Jul 27, 2022

    Myelofibrosis, Primary Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis Trial in Worldwide (parsaclisib, ruxolitinib,

    Recruiting
    • Myelofibrosis
    • +3 more
    • Berkeley, California
    • +176 more
    Dec 1, 2022

    Myelofibrosis, Primary Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis Trial in Worldwide (parsaclisib, ruxolitinib,

    Recruiting
    • Myelofibrosis
    • +3 more
    • Anchorage, Alaska
    • +172 more
    Dec 1, 2022

    Cancer Trial in Indianapolis, Pittsburgh, Memphis (MAAT-YS)

    Not yet recruiting
    • Cancer
    • MAAT-YS
    • Indianapolis, Indiana
    • +2 more
    Nov 27, 2023

    Stasis Dermatitis Trial in United States (crisaborole ointment, vehicle ointment)

    Completed
    Has Results
    • Stasis Dermatitis
    • crisaborole ointment
    • vehicle ointment
    • El Segundo, California
    • +3 more
    Apr 1, 2022